TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
TMRW Life Sciences has raised $28.2M in total funding. The most recent round was Series D. The last funding was announced in July 2024.
TMRW Life Sciences's investors include 5AM Ventures, Transformation Capital, Google Ventures, Presight Capital, Casdin Capital.
TMRW Life Sciences is headquartered in New York, United States.
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
TMRW Life Sciences is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TMRW Life Sciences — Funding & Investors." VCBacked, July 12, 2024, https://www.vcbacked.co/company/tmrw-life-sciences. Accessed October 17, 2026.
VCBacked. (2024). TMRW Life Sciences — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/tmrw-life-sciences
{{cite web |title=TMRW Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/tmrw-life-sciences |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated